OraSure Technologies, Inc. announced it has been awarded a $710,310 contract from the Biomedical Advanced Research and Development Authority, part of the Department of Health and Human Services, to develop a pan-SARS-coronavirus antigen rapid in-home self-test that uses oral fluid samples.
April 6, 2020
· 8 min read